By Colin Kellaher
Innate Pharma has hired Jonathan Dickinson as the clinical-stage biotechnology company's next chief executive.
Innate said Dickinson, who most recently served as executive vice president and general manager for Europe at Incyte, joins the France-based company on Nov. 1 and will also serve as chairman of the executive board.
Herve Brailly, Innate's co-founder, has been serving as interim CEO and executive board chairman since the departure of Mondher Mahjoubi in January.
Innate said Brailly will remain for the next few months in an advisory role to assist with the transition, adding that it will propose that he join the board at the next opportunity.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 14, 2024 07:40 ET (11:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。